1-(4-hydroxy-3-methoxyphenyl)-7-(3-methoxy-4-((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)phenyl)hepta-1,6-diene-3,5-dione

ID: ALA4517144

PubChem CID: 9807012

Max Phase: Preclinical

Molecular Formula: C27H30O11

Molecular Weight: 530.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)ccc1O

Standard InChI:  InChI=1S/C27H30O11/c1-35-21-11-15(5-9-19(21)31)3-7-17(29)13-18(30)8-4-16-6-10-20(22(12-16)36-2)37-27-26(34)25(33)24(32)23(14-28)38-27/h3-12,23-28,31-34H,13-14H2,1-2H3/b7-3+,8-4+/t23-,24-,25+,26-,27?/m1/s1

Standard InChI Key:  LVMBIHPDKVZZOB-GARRWRKTSA-N

Molfile:  

 
     RDKit          2D

 38 40  0  0  0  0  0  0  0  0999 V2000
   28.6017   -2.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3094   -2.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8940   -2.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3094   -1.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0171   -2.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8940   -1.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.1863   -2.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4786   -2.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7248   -2.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4325   -2.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7709   -2.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0638   -2.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3566   -2.9635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3562   -3.7816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0688   -4.1900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7732   -3.7797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4302   -3.7857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1371   -4.1943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8458   -3.7856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8432   -2.9642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1357   -2.5594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5494   -2.5531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.2586   -2.9592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5540   -4.1933    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.6491   -2.5546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.6495   -1.7374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6490   -4.1911    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.5551   -5.0104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8496   -5.4158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.8488   -6.2294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5552   -6.6409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2642   -6.2326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2667   -5.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1401   -6.6363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4334   -6.2260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.5532   -7.4581    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.9710   -6.6427    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.9732   -5.0021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  2  0
  2  5  1  0
  3  6  2  0
  3  7  1  0
  7  8  2  0
  5  9  2  0
  9 10  1  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 10 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 10  1  0
 20 22  1  0
 22 23  1  0
 19 24  1  0
 13 25  1  0
 25 26  1  0
 14 27  1  0
 24 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 30 34  1  1
 34 35  1  0
 31 36  1  6
 32 37  1  1
 33 38  1  6
M  END

Associated Targets(Human)

AGS (1999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 530.53Molecular Weight (Monoisotopic): 530.1788AlogP: 0.84#Rotatable Bonds: 11
Polar Surface Area: 172.21Molecular Species: NEUTRALHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.28CX Basic pKa: CX LogP: 1.86CX LogD: 1.85
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.21Np Likeness Score: 1.42

References

1. Rodrigues FC, Anil Kumar NV, Thakur G..  (2019)  Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.,  177  [PMID:31129455] [10.1016/j.ejmech.2019.04.058]

Source